COLUMBUS, OH., 2 June, 2011–Battelle, the world’s largest independent research and development organization, continues to advance human health with its new, comprehensive Molecular Imaging Solutions portfolio.
Battelle uniquely combines the engineering, scientific and diagnostic proficiency of its medical device experts with industry-leading life science capabilities to deliver highly differentiated services. This gives manufacturers an integrated solution from a single service provider across the broad spectrum of molecular imaging needs, including:
- Molecular targets (gene expression profiling, proteomics)
- Chemistry (nanoparticles, combinatorial chemistry)
- Molecular/cellular biology (cell delivery, spatial localization of targets)
- Biomarker development and validation
- Nonclinical imaging (equipment development, pharmacokinetics, toxicology)
- Computer modeling (image reconstruction, statistical analysis)
- Clinical imaging equipment development (controlled delivery RP power injectors, scanners, cameras, RP generator/synthesizer)
- Medical isotope testing laboratory and radioactive material (RAM) license
“The unique ability to draw from the collective experience and expertise across Battelle’s vast network of science and technology disciplines for improved imaging services allows us to advance human health and to boost our clients’ product-development pipelines,” said Barbara Kunz, president of Battelle’s Health and Life Sciences Global Business.
Battelle will feature its innovative new molecular imaging services at booth no. 3026 at the Society of Nuclear Medicine Annual Conference, June 4-6, in San Antonio, Texas.
“Battelle’s expert teams in medical devices and diagnostics; safety and efficacy testing; and biomarkers and assay development work together to dramatically improve imaging services to advance human health,” said Chad Bouton, research leader.
As the world’s largest independent research and development organization, Battelle provides innovative solutions to the world’s most pressing needs through its four global businesses: Laboratory Management; National Security; Health and Life Sciences; and Energy, Environment and Material Sciences. It advances scientific discovery and application by conducting $6.2 billion in global R&D annually through contract research, laboratory management and technology commercialization.
Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including eight national laboratories for which Battelle has a significant management role on behalf of the U.S. Department of Energy, the U.S. Department of Homeland Security, and the United Kingdom.
Battelle also is one of the nation’s leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science, technology, engineering and mathematics (STEM) education.
For more information contact Katy Delaney at (614) 424-7208 or firstname.lastname@example.org, or T.R. Massey at (614) 424-5544 or email@example.com.